Biotech and Pharma Industry News | BioPharma Dive
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
News - BioSpace
The latest biotech and pharmaceutical news from BioSpace
BioSpace: Biotech, Pharmaceutical and Clinical Research News
Dec 11, 2010 · Madrigal Pharmaceuticals, X4 Pharmaceuticals and Day One Biopharmaceuticals secured their maiden approvals this year in metabolic dysfunction-associated steatohepatitis, WHIM syndrome and pediatric low-grade glioma. Geron …
The biopharma industry outlook on 2024: Guarded optimism for a …
Jan 16, 2024 · Biotech IPOs are the industry’s lifeblood. Track how they’re performing. Ascentage Pharma, a China-based cancer drug developer aligned with Takeda, outlined what could be the year’s first new biotech stock offering.
Biotech News - BioPharma Dive
Jan 2, 2025 · The biotech will cut 180 positions, or about two-thirds of its workforce, and discontinue development of its lead drug candidate reni-cel. By Ned Pagliarulo • Updated Dec. 13, 2024
Sarepta, Biotech’s Regulatory Go-Getter, Signs Standout
Dec 4, 2024 · That is, until it dropped a massive licensing agreement last week with Arrowhead Pharmaceuticals. Sarepta is putting down $500 million upfront and a $325 million equity investment in the near term, plus up to $10 billion in milestones and other payments.
Biotech startups are built on venture capital. Track funding rounds ...
Nov 21, 2024 · This group was selected by comparing data from SVB, HSBC, William Blair and Bay Bridge Bio that identified the most active biotech venture capital firms in 2023 (SVB, HSBC, William Blair), 2022 (SVB), 2021 (SVB) and in 2018 to 2023 (Bay Bridge Bio).
5 questions facing emerging biotech in 2024 - BioPharma Dive
Jan 8, 2024 · Yet drugmaking platforms are the foundation of some of the sector’s largest companies, like Alnylam Pharmaceuticals and Moderna. They can pioneer new ways to develop medicines, enabling companies to treat previously intractable diseases or reach tough drug targets. In the current environment, though, platform biotechs are in a tough spot.
Nereus Pharmaceuticals, Inc. Raises $45 Million in Series D
Aug 9, 2007 · About Nereus Pharmaceuticals, Inc. Nereus Pharmaceuticals pursues novel sources of chemical diversity to discover and develop new therapeutics. Using its unmatched expertise in marine microbiology to identify unique biologically active compounds, the Company has placed two oncology drug candidates in Phase I clinical trials in the past 12 months.
The Top 6 Pharmaceutical Companies in New Jersey - BioSpace
Jun 23, 2017 · New Jersey is one of the most important states in the U.S. pharmaceutical industry. The state is home to 14 of the 20 largest pharmaceutical companies in the U.S., and the New Jersey pharmaceutical industry generates over $120.9 billion in revenue each year, with 63,415 jobs directly linked to the industry.